The analysis revealed that AHNAK2 was expressed at higher levels in several malignancies compared to normal tissues, including lung adenocarcinoma, kidney renal papillary cell carcinoma, head and neck squamous cell carcinoma, kidney renal clear cell carcinoma, and PAAD. This evidence concerns the gene AHNAK2 and head and neck squamous cell carcinoma.